Mitchell Sinkler & Starr’s United Therapeutics UTHR Stock Holding History

Mitchell Sinkler & Starr’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$241K	Buy	+445	New	+$251K	0.1%	143

Other funds holding UTHR

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Mitchell Sinkler & Starr's UTHR Position: Q2 2026 in Review

Mitchell Sinkler & Starr opened a new position in United Therapeutics (UTHR) in Q2 2026: 445 shares worth $241K. The stake represents 0.1% of the portfolio and ranks #143 among its holdings.

172 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Mitchell Sinkler & Starr held 445 shares of United Therapeutics worth $241K as of Q2 2026.
United Therapeutics was a new Mitchell Sinkler & Starr position in Q2 2026.
United Therapeutics made up 0.1% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #143 holding.
172 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.